Cipla inks pact to sell 51% stake in Uganda-based unit to Africa Capitalworks

Africa Capitalworks is a wholly owned subsidiary of Africa Capitalworks Holdings (ACW), an investment management company incorporated in Mauritius.

Cipla inks pact to sell 51% stake in Uganda-based unit to Africa Capitalworks
Consideration to be received by Cipla (EU) Ltd and Meditab Holdings Limited shall be in the range of USD 25-30 million, Cipla noted. (Photo credit: Reuters)

Drug major Cipla on Tuesday said it has inked a pact with Africa Capitalworks to sell a 51.18 per cent stake in Uganda-based Cipla Quality Chemical Industries Ltd.

The company and its wholly-owned subsidiaries, Cipla (EU) Ltd and Mauritius-based Meditab Holdings Ltd, have entered into a share purchase agreement with Africa Capitalworks on March 14, Cipla said in a regulatory filing.

Subsequent to the sale, Cipla Quality Chemical Industries (CQCIL) will cease to be a subsidiary of the company, it added.

Consideration to be received by Cipla (EU) Ltd and Meditab Holdings Limited shall be in the range of USD 25-30 million, Cipla noted.

The proposed sale is expected to be completed by May 31, 2023, it added.

Africa Capitalworks is a wholly owned subsidiary of Africa Capitalworks Holdings (ACW), an investment management company incorporated in Mauritius.

ACW is engaged in providing permanent equity capital and complementary skills to mid-market companies across Sub-Saharan Africa.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-mutual-fund-sip-retirement-corpus-planning-calculator-how-many-years-it-will-take-to-reach-inr-rs-30000000-with-4000-5000-and-6000-monthly-investment-market-linked-return-324325

Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000

https://www.zeebiz.com/personal-finance/news-sip-mutual-fund-power-of-compounding-retirement-corpus-planning-calculator-salary-inr-rs-25000-per-month-is-it-possible-to-create-over-26367030-fund-calculations-324366

Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations

https://www.zeebiz.com/personal-finance/news-reduce-home-loan-emi-or-reduce-tenure-rs-75-lakh-25-year-home-loan-which-option-can-save-rs-25-lakh-and-64-months-and-how-know-here-324393

Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-large-and-mid-cap-sip-mutual-funds-with-highest-best-xirr-returns-in-5-years-no-1-scheme-has-turned-rs-inr-15000-monthly-investment-into-rs-2054384-uti-icici-hdfc-bank-hsbc-quant-motilal-324344

Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others

https://www.zeebiz.com/markets/stocks/photo-gallery-stock-to-buy-for-long-term-on-new-year-samvat-2081-by-anil-singhvi-iifl-finance-share-price-target-nse-bse-smallcap-stock-324310

New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-pnb-hdfc-bank-3-year-senior-citizen-fd-fixed-deposit-interest-rate-maturity-return-calculator-which-bank-gives-highest-on-inr-rs-500000-investment-state-bank-of-india-punjab-national-guaranteed-return-scheme-324094

Senior Citizen FD: SBI 3-year FD vs PNB 3-year FD vs HDFC Bank 3-year FD; which FD will give highest return on Rs 5 lakh investment

Reported By: PTI
Updated: Wed, Mar 15, 2023
11:31 AM IST
New Delhi, PTI
RELATED NEWS
Cipla shares surge nearly 10% after positive USFDA update on Goa facility Cipla shares surge nearly 10% after positive USFDA update on Goa facility
Cipla Q2 earnings preview: Margins under pressure as US, domestic sales outlook remains modest Cipla Q2 earnings preview: Margins under pressure as US, domestic sales outlook remains modest
Cipla Vice Chairman MK Hamied steps down Cipla Vice Chairman MK Hamied steps down
Cipla Q1 preview: Pharma major to likely report low double-digit growth in PAT; margins seen to remain steady Cipla Q1 preview: Pharma major to likely report low double-digit growth in PAT; margins seen to remain steady
Cipla receives income tax demand of Rs 773 crore Cipla receives income tax demand of Rs 773 crore

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x